Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Final Results of a Phase 1 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Patients with Relapsed or Refractory Myeloma

Autor:	Vogl, Dan T., Stadtmauer, Edward A. *, Bradner, James *, Davis, Lisa *, Paul, Thomas M. *, Scott, Emma C., Nichols, Charles W. *, Porter, David L., Carroll, Martin, Kaplan, Janeen *, Mallon, Gayle *, Swider, Cezary R. *, Mangan, Patricia A. *, Shelly, Brenda K. *, Amaravadi, Ravi K. *
Zdroj:	In Blood 18 November 2011 118(21):1869-1869
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu